GHK-Cu has been shown to regulate over 4,000 human genes in research settings, including upregulation of tissue repair genes and downregulation of genes associated with inflammatory and oxidative damage pathways
the FDA has stated it lacks sufficient information to know whether the substance would cause harm when administered to humans Evidence snapshot: The evidence base is almost entirely preclinical, decades of animal (largely rat) studies, mostly from one Croatian research group (Sikiric et al., University of Zagreb), with a single small human trial under the brand name "Bepecin" (around 2015) that did not lead to any FDA-approved use
Other common contaminants include bacterial byproducts that can cause life-threatening sepsis
Injections of micronutrient B12 at larger doses may be necessary for older persons to keep their vitamin levels appropriate
FAK and paxillin proteins also impact cancer biology that can help aggressive cancers grow, and the risk is BPC-157 could do the same
A locally activatable sensor for robust quantification of organellar glutathione